Kinetin and Kinerase Pro+Therapy Line day repair, serum, night repair and Kinerase Pro+Therapy Line Ultra rich day repair in Skin Aging - Clinical Trials Registry

Study Overview

Status

Terminated

Conditions

Skin Aging

Intervention / Treatment

Study Type

Interventional

Phase

Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

United States
- California
  - Santa Ana, California, United States, 92701
    - Steve Yoelin MD practice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

Female patients 35-55 years of age with at least moderate signs of facial aging
Written informed consent
Likely to complete all study visits and follow study protocol

Exclusion Criteria:

Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements
Known hypersensitivity to any study product or their components
Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures)
Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments)
Planned facial procedures during the study (microdermabrasion, facials, etc)
o Botox and fillers cannot be used during the trial or for 3 months prior to study entry
Recent (within 60 days) or concurrent participation in another clinical trial
Concomitant topical or systemic therapy that my interfere with study measurements or outcomes
Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens
Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study
Wearing of cosmetics during study visits

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Allocation: Randomized
Interventional Model: Parallel Assignment
Masking: Single

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Innovative Medical

Investigators

Principal Investigator: Steven Yoelin, MD, Private practice

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2007

Primary Completion

December 7, 2022

Study Completion (Actual)

December 1, 2007

Study Registration Dates

First Submitted

June 25, 2007

First Submitted That Met QC Criteria

June 26, 2007

First Posted (Estimate)

June 27, 2007

Study Record Updates

Last Update Posted (Estimate)

December 24, 2007

Last Update Submitted That Met QC Criteria

December 18, 2007

Last Verified